• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Are Canine Cancer Sniffers the Real Deal?

April 2, 2018
JoAnna Pendergrass, DVM

Results of a recent study suggest that dogs may be useful in identifying potential biomarkers for lung cancer in people.

Lung cancer is a common cancer in Europe. A 2012 study reported that it was the third most common cancer (410,000 cases) and the most common cause of death from cancer (353,000 deaths) in Europe, highlighting the need for early and accurate diagnostic lung cancer testing.

Previous studies have used gas chromatography-mass spectrometry to identify several volatile organic compounds (VOCs; i.e., 1-butanol and 2-pentanone) as potential lung cancer biomarkers; these VOCs were found in greater concentrations in the breath of patients with lung cancer than in that of healthy patients. Interestingly, several studies have described dogs’ olfactory ability to detect these potential biomarkers. However, the reported sensitivities and specificities for this detection ability varied widely.

To date, few studies have investigated dogs’ cancer-detecting abilities alongside instrumental VOC analysis. In addition, no single VOC or combination of VOCs has reached clinically relevant specificity and sensitivity for disease recognition. In a proof of concept study recently published in Frontiers in Veterinary Science, a German research team determined that dogs could be a valuable tool for lung cancer diagnosis.

RELATED:

  • Enlisting Dogs in the War on Cancer
  • How Canine Brain Cancer Studies Could Help Humans, Too​​​​​​​

Sample Collection and Training

The researchers obtained “genuine” breath samples from 30 patients with lung cancer who had not yet begun treatment and 30 healthy patients. They also prepared 4 synthetic air samples containing several VOCs: 1-butanol, 2-butanone, 2-pentanone, and hexanal. All samples were placed in fleece-lined sample tubes that were then placed within cones. These breath samples were used for training and testing.

Advertisement

Four female pet dogs of various breeds were trained to distinguish between breath samples from patients with lung cancer and healthy patients; sniffing of the cancer-positive samples was immediately rewarded with a treat. Only 2 of the dogs—a Labrador and poodle—successfully completed training and were used for testing.

Testing and Results

The dogs first underwent several trials to distinguish between breath samples from patients with lung cancer (n=9) and healthy patients (n=10). In the testing room for each trial, several sample-containing cones were positioned in front of the dog. The dog’s initial contact with each sample was analyzed: sitting near a sample or pointing the nose at it indicated positive (lung cancer) and walking away from a sample indicated negative (healthy). Dogs had to indicate positive or negative for all samples, and correct positive indications were rewarded with a food treat.

Of the 9 samples from patients with lung cancer, the Labrador correctly identified all 9 and the poodle identified 8 as positive. Of 10 samples from healthy patients, the Labrador correctly identified 8 and the poodle identified 4 as negative.

Next, the dogs distinguished between the synthetic air samples (n=4) and samples from healthy patients (n=10). Each dog correctly identified 3 synthetic air samples as positive.

Bringing It Together

The researchers acknowledged several study limitations, particularly the low number of dogs used for testing. However, they noted, the results still provide proof of concept. Because of this, the researchers believe that “specially trained detection dogs are a useful tool for finding the best possible biomarker for an effective diagnostic system for lung cancer.”

For future research on using dogs for detecting human cancer, the researchers suggested determining specific selection criteria for detection dogs and evaluating more combinations of VOCs that could be lung cancer biomarkers.

Dr. Pendergrass received her Doctor of Veterinary Medicine degree from the Virginia-Maryland College of Veterinary Medicine. Following veterinary school, she completed a postdoctoral fellowship at Emory University’s Yerkes National Primate Research Center. Dr. Pendergrass is the founder and owner of JPen Communications, a medical communications company.


Advertisement

Latest News

What's new with the "Dentistry Lane" across the veterinary profession?

Meet the BlackDVM Network

Study finds certain canine breeds should be screened for cancer at young ages

AVMA releases 2 videos informing pet parents on pet dental care

View More Latest News
Advertisement